Scientific Publication

Treatment interruption and directly observed treatment of multidrug-resistant tuberculosis patients in China

author(s) Wei, X.L. - Yin, J. - Zou, G.Y.. - Zhang, Z-T. - Walley, J. - Harwell, J. - Li, HT. - Sun, Q. - Li, RZ. - Zhang, X-L. - Wang, L-X.
from UK Foreign, Commonwealth & Development Office (FCDO)
permalink open
themes
regions
  • Eastern Asia
  • Asia
  • World
citation

X-L. Wei, J. Yin, G-Y. Zou, Z-T. Zhang, J. Walley, J. Harwell, H-T. Li, Q. Sun, R-Z. Li,L-X. Wang, X-L. Zhang. Treatment interruption and directly observed treatment of multidrug-resistant tuberculosis patients in China The International Journal of Tuberculosis and Lung Disease Vol 19, Number 4 (2015) pp 413-19 DOI: 10.5588/ijtld.14.0485 (Subscription or purchase of article required)

Publications and datasets provided via GARDIAN

Abstract

China has nearly one fifth of global multidrug-resistant tuberculosis (MDR-TB) cases, and follows the 24-month World Health Organization standardised regimens. This paper aims to assess treatment interruption among MDR-TB patients and its association with the provision of directly observed treatment This research is supported by the Department for International Development’s COMDIS–HSD Programme which is led by the University of Leeds

Open original